Oppenheimer Asset Management Inc. Has $8.12 Million Stake in Haleon plc (NYSE:HLN)

Oppenheimer Asset Management Inc. lowered its position in Haleon plc (NYSE:HLN - Free Report) by 7.0% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 767,602 shares of the company's stock after selling 58,073 shares during the quarter. Oppenheimer Asset Management Inc.'s holdings in Haleon were worth $8,121,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in HLN. AE Wealth Management LLC lifted its position in shares of Haleon by 6.1% during the second quarter. AE Wealth Management LLC now owns 19,199 shares of the company's stock worth $159,000 after purchasing an additional 1,098 shares in the last quarter. Cardinal Capital Management grew its holdings in shares of Haleon by 2.5% during the 2nd quarter. Cardinal Capital Management now owns 46,231 shares of the company's stock valued at $382,000 after purchasing an additional 1,140 shares during the last quarter. Lake Street Advisors Group LLC grew its holdings in Haleon by 5.4% during the 3rd quarter. Lake Street Advisors Group LLC now owns 22,395 shares of the company's stock worth $237,000 after acquiring an additional 1,143 shares during the last quarter. Endowment Wealth Management Inc. lifted its position in shares of Haleon by 9.9% in the 2nd quarter. Endowment Wealth Management Inc. now owns 12,867 shares of the company's stock worth $106,000 after purchasing an additional 1,161 shares during the period. Finally, Portside Wealth Group LLC lifted its position in shares of Haleon by 2.7% during the 2nd quarter. Portside Wealth Group LLC now owns 44,985 shares of the company's stock valued at $372,000 after acquiring an additional 1,182 shares during the period. 6.67% of the stock is currently owned by institutional investors.

Haleon Trading Up 0.9 %

Shares of Haleon stock traded up $0.08 during trading on Friday, hitting $9.39. The stock had a trading volume of 6,227,277 shares, compared to its average volume of 5,273,700. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. Haleon plc has a 12 month low of $7.89 and a 12 month high of $10.80. The firm's fifty day simple moving average is $10.12 and its 200-day simple moving average is $9.33. The stock has a market cap of $42.51 billion, a PE ratio of 27.34, a PEG ratio of 2.79 and a beta of 0.30.

Wall Street Analyst Weigh In

A number of research analysts have commented on the stock. Berenberg Bank began coverage on shares of Haleon in a research report on Tuesday, August 6th. They set a "buy" rating on the stock. Morgan Stanley upped their price objective on Haleon from $9.90 to $10.95 and gave the stock an "overweight" rating in a report on Friday, September 20th. UBS Group upgraded Haleon to a "strong-buy" rating in a research report on Tuesday, October 1st. Finally, The Goldman Sachs Group lowered Haleon from a "buy" rating to a "neutral" rating in a research note on Tuesday, August 6th. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Haleon presently has a consensus rating of "Buy" and a consensus target price of $10.95.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.